Syros Pharmaceut lost $5.81 per diluted share in fiscal year 2023. Over the trailing 12 months, Q4 FY2023 through Q3 FY2024, the same line adds up to a loss of $3.07 per diluted share. The table below carries 10 fiscal years, from 2014 to 2023, and the quarters Syros Pharmaceut has filed alongside them.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.
What was Syros Pharmaceut's diluted earnings per share in fiscal year 2023?
Syros Pharmaceut lost $5.81 per diluted share in fiscal year 2023.
What is Syros Pharmaceut's diluted earnings per share over the last twelve months?
Syros Pharmaceut (SYRS) reported a loss of $3.07 per diluted share over the trailing 12 months, Q4 FY2023 through Q3 FY2024, summed from the four most recent quarterly filings.
What was Syros Pharmaceut's diluted earnings per share in the most recent quarter?
Syros Pharmaceut (SYRS) reported -$0.16 in diluted earnings per share in Q3 2024. This represents an increase of 88.8% from the same quarter a year earlier.
What does diluted earnings per share mean on a financial statement?
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Syros Pharmaceut (SYRS) reported on that line in every period on record.
